top of page

Search


MAVACAMTEN: First and only cardiac myosin inhibitor
1. Introduction Mavacamten, marketed under the brand name Camzyos, is a first-in-class cardiac myosin inhibitor developed by Bristol...
ACS BCP
May 253 min read
43
0
Regulatory T Cells and CAR-T Technology: A New Era in Immune Modulation
Introduction Regulatory T cells (Tregs) are a specialized subset of immune cells that regulate immune responses and maintain homeostasis....
ACS BCP
Mar 93 min read
28
0


How Microgravity Alters Bacteria: The Case of Mycobacterium marinum
Introduction Space is an extreme environment, and understanding how bacteria adapt to it is crucial for astronaut health and long-term...
ACS BCP
Mar 24 min read
17
0


The Cosmic Palette: What Colors Tell Us About The Universe.
A Universe Painted in Light. Imagine the universe as a vast canvas, where every celestial object is a brushstroke of color revealing...
ACS BCP
Feb 233 min read
62
0


"Resmetirom: The Breakthrough NASH Treatment We’ve Been Waiting For?"
I ntroduction Resmetirom is the first drug approved to treat non-alcoholic steatohepatitis (NASH) with moderate to advanced liver...
ACS BCP
Feb 163 min read
59
0
bottom of page